Letrozole Tablet In Kolkata

MOQ10 Box/Boxes

Drug TypeGeneral Medicines

Physical FormTablets

Suitable ForSuitable For All

Storage InstructionsCool & Dry Place

MOQ100 Box/Boxes

Enzyme TypesStabilizers

FeatureFood Grade, Dry Enzyme

Physical Color/TextureWhite Powder

Fermentation SmellStrong Smell

Storage InstructionsCool And Dry Place

Shelf Life24 Months

MOQ100 Unit/Units

Supply Ability100000 Per Month

Delivery Time10-15 Days

MOQ100 Strip/Strips

Origin of MedicineIndia

Pacakaging (Quantity Per Box)10*10 Tablets

Physical FormTablets

Dosage2.5 mg

Dosage GuidelinesPrescription

Suitable ForAdults, Aged Person

MOQ100 Box/Boxes

Drug TypeGeneral Medicines

Physical FormTablets

Dosage GuidelinesAs per the doctor's advice

Storage InstructionsKeep at cool and Dry Place

MOQ10 Strip/Strips

Salt CompositionLetrozole 2.5mg

Pacakaging (Quantity Per Box)10 strips per box

Origin of MedicineSynthetic

Drug TypeOther, Anti-cancer medication

IngredientsLetrozole

Physical FormOther, Tablet

MOQ100 Tablet

Drug TypeGeneric Drugs

Physical FormTablets

Suitable ForSuitable For All

Quantity3x10 Strip

Storage InstructionsCool & Dry Place

MOQ100 Unit/Units

Dosage FormTablet

OriginIndia

Fermentation SmellNormal Smell

Storage InstructionsDry place

Shelf Life12-24 Months

MOQ1 Strip/Strips

IngredientsOther

ApplicationOther

Storage InstructionsCool & Dry Place

MOQ15 Tablet

Payment TermsWestern Union, Cash Advance (CA), Cash in Advance (CID)

Supply Ability1000 Per Day

Delivery Time10 Days

Product DescriptionWith the help of skilled professionals and good knowledgeable experience, we are involved in supplying and manufacturing quality-assured spectrum of Letroz Tablets in Mumbai, Maharashtra, India. It is used to prevent cancer from happening again. It can be used as first treatment before breast cancer

MOQ10 Box/Boxes

Drug TypeSpecific Drug

IngredientsLETROZOLE 2.5MG

Physical FormTablets

FunctionCancer Treatment

Recommended ForBREAST CANCER,INFERTILITY DUE TO ANOVULATION

Dosagedult and elderly patients The recommended dose of Letrozole Tablets is 2.5 mg once daily. No dose adjustment is required for elderly patients. In patients with advanced or metastatic breast cancer, treatment with Letrozole Tablets should continue until tumour progression is evident. In the adjuvant and extended adjuvant setting, treatment with Letrozole Tablets should continue for 5 years or until tumour relapse occurs, whichever is first. In the adjuvant setting a sequential treatment schedule (letrozole 2 years followed by tamoxifen 3 years) could also be considered (see sections 4.4 and 5.1). In the neoadjuvant setting, treatment with Letrozole tablet could be continued for 4 to 8 months in order to establish optimal tumour reduction. If the response is not adequate, treatment with Letrozole tablet should be discontinued and surgery scheduled and/or further treatment options discussed with the patient.